Neuroscience Antibodies and Assays Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Hospitals & Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Market Perspective (2017-2028)
2.2 Neuroscience Antibodies and Assays Growth Trends by Region
2.2.1 Neuroscience Antibodies and Assays Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neuroscience Antibodies and Assays Historic Market Size by Region (2017-2022)
2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Region (2023-2028)
2.3 Neuroscience Antibodies and Assays Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Industry Trends
2.3.2 Neuroscience Antibodies and Assays Market Drivers
2.3.3 Neuroscience Antibodies and Assays Market Challenges
2.3.4 Neuroscience Antibodies and Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2017-2022)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2017-2022)
3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue
3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2021
3.5 Neuroscience Antibodies and Assays Key Players Head office and Area Served
3.6 Key Players Neuroscience Antibodies and Assays Product Solution and Service
3.7 Date of Enter into Neuroscience Antibodies and Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2017-2022)
4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2023-2028)
5 Neuroscience Antibodies and Assays Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2017-2022)
5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size (2017-2028)
6.2 North America Neuroscience Antibodies and Assays Market Size by Type
6.2.1 North America Neuroscience Antibodies and Assays Market Size by Type (2017-2022)
6.2.2 North America Neuroscience Antibodies and Assays Market Size by Type (2023-2028)
6.2.3 North America Neuroscience Antibodies and Assays Market Share by Type (2017-2028)
6.3 North America Neuroscience Antibodies and Assays Market Size by Application
6.3.1 North America Neuroscience Antibodies and Assays Market Size by Application (2017-2022)
6.3.2 North America Neuroscience Antibodies and Assays Market Size by Application (2023-2028)
6.3.3 North America Neuroscience Antibodies and Assays Market Share by Application (2017-2028)
6.4 North America Neuroscience Antibodies and Assays Market Size by Country
6.4.1 North America Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
6.4.2 North America Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size (2017-2028)
7.2 Europe Neuroscience Antibodies and Assays Market Size by Type
7.2.1 Europe Neuroscience Antibodies and Assays Market Size by Type (2017-2022)
7.2.2 Europe Neuroscience Antibodies and Assays Market Size by Type (2023-2028)
7.2.3 Europe Neuroscience Antibodies and Assays Market Share by Type (2017-2028)
7.3 Europe Neuroscience Antibodies and Assays Market Size by Application
7.3.1 Europe Neuroscience Antibodies and Assays Market Size by Application (2017-2022)
7.3.2 Europe Neuroscience Antibodies and Assays Market Size by Application (2023-2028)
7.3.3 Europe Neuroscience Antibodies and Assays Market Share by Application (2017-2028)
7.4 Europe Neuroscience Antibodies and Assays Market Size by Country
7.4.1 Europe Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
7.4.2 Europe Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2017-2028)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type
8.2.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neuroscience Antibodies and Assays Market Share by Type (2017-2028)
8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application
8.3.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neuroscience Antibodies and Assays Market Share by Application (2017-2028)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region
8.4.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Market Size (2017-2028)
9.2 Latin America Neuroscience Antibodies and Assays Market Size by Type
9.2.1 Latin America Neuroscience Antibodies and Assays Market Size by Type (2017-2022)
9.2.2 Latin America Neuroscience Antibodies and Assays Market Size by Type (2023-2028)
9.2.3 Latin America Neuroscience Antibodies and Assays Market Share by Type (2017-2028)
9.3 Latin America Neuroscience Antibodies and Assays Market Size by Application
9.3.1 Latin America Neuroscience Antibodies and Assays Market Size by Application (2017-2022)
9.3.2 Latin America Neuroscience Antibodies and Assays Market Size by Application (2023-2028)
9.3.3 Latin America Neuroscience Antibodies and Assays Market Share by Application (2017-2028)
9.4 Latin America Neuroscience Antibodies and Assays Market Size by Country
9.4.1 Latin America Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
9.4.2 Latin America Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2017-2028)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type
10.2.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neuroscience Antibodies and Assays Market Share by Type (2017-2028)
10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application
10.3.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neuroscience Antibodies and Assays Market Share by Application (2017-2028)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country
10.4.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.1.5 Thermo Fisher Recent Developments
11.2 Abcam
11.2.1 Abcam Company Details
11.2.2 Abcam Business Overview
11.2.3 Abcam Neuroscience Antibodies and Assays Introduction
11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.2.5 Abcam Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.3.5 Bio-Rad Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Neuroscience Antibodies and Assays Introduction
11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.4.5 Merck Recent Developments
11.5 Cell Signaling Technology
11.5.1 Cell Signaling Technology Company Details
11.5.2 Cell Signaling Technology Business Overview
11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.5.5 Cell Signaling Technology Recent Developments
11.6 Genscript
11.6.1 Genscript Company Details
11.6.2 Genscript Business Overview
11.6.3 Genscript Neuroscience Antibodies and Assays Introduction
11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.6.5 Genscript Recent Developments
11.7 Rockland Immunochemicals
11.7.1 Rockland Immunochemicals Company Details
11.7.2 Rockland Immunochemicals Business Overview
11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.7.5 Rockland Immunochemicals Recent Developments
11.8 BioLegend
11.8.1 BioLegend Company Details
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.8.5 BioLegend Recent Developments
11.9 Santa Cruz Biotechnology
11.9.1 Santa Cruz Biotechnology Company Details
11.9.2 Santa Cruz Biotechnology Business Overview
11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.9.5 Santa Cruz Biotechnology Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Neuroscience Antibodies and Assays Introduction
11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.10.5 Roche Recent Developments
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Neuroscience Antibodies and Assays Introduction
11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
11.11.5 Siemens Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Consumables
Table 3. Key Players of Instruments
Table 4. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Neuroscience Antibodies and Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Neuroscience Antibodies and Assays Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Neuroscience Antibodies and Assays Market Share by Region (2017-2022)
Table 8. Global Neuroscience Antibodies and Assays Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Neuroscience Antibodies and Assays Market Share by Region (2023-2028)
Table 10. Neuroscience Antibodies and Assays Market Trends
Table 11. Neuroscience Antibodies and Assays Market Drivers
Table 12. Neuroscience Antibodies and Assays Market Challenges
Table 13. Neuroscience Antibodies and Assays Market Restraints
Table 14. Global Neuroscience Antibodies and Assays Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Neuroscience Antibodies and Assays Revenue Share by Players (2017-2022)
Table 16. Global Top Neuroscience Antibodies and Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2021)
Table 17. Ranking of Global Top Neuroscience Antibodies and Assays Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neuroscience Antibodies and Assays Product Solution and Service
Table 21. Date of Enter into Neuroscience Antibodies and Assays Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuroscience Antibodies and Assays Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2017-2022)
Table 25. Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2023-2028)
Table 27. Global Neuroscience Antibodies and Assays Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Neuroscience Antibodies and Assays Revenue Share by Application (2017-2022)
Table 29. Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Neuroscience Antibodies and Assays Revenue Share by Application (2023-2028)
Table 31. North America Neuroscience Antibodies and Assays Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Neuroscience Antibodies and Assays Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Neuroscience Antibodies and Assays Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Neuroscience Antibodies and Assays Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Neuroscience Antibodies and Assays Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Neuroscience Antibodies and Assays Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Neuroscience Antibodies and Assays Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Neuroscience Antibodies and Assays Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Neuroscience Antibodies and Assays Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Neuroscience Antibodies and Assays Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Neuroscience Antibodies and Assays Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Neuroscience Antibodies and Assays Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Neuroscience Antibodies and Assays Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Neuroscience Antibodies and Assays Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Neuroscience Antibodies and Assays Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Neuroscience Antibodies and Assays Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Neuroscience Antibodies and Assays Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Neuroscience Antibodies and Assays Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Neuroscience Antibodies and Assays Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Neuroscience Antibodies and Assays Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Neuroscience Antibodies and Assays Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Neuroscience Antibodies and Assays Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
Table 61. Thermo Fisher Company Details
Table 62. Thermo Fisher Business Overview
Table 63. Thermo Fisher Neuroscience Antibodies and Assays Product
Table 64. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 65. Thermo Fisher Recent Developments
Table 66. Abcam Company Details
Table 67. Abcam Business Overview
Table 68. Abcam Neuroscience Antibodies and Assays Product
Table 69. Abcam Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 70. Abcam Recent Developments
Table 71. Bio-Rad Company Details
Table 72. Bio-Rad Business Overview
Table 73. Bio-Rad Neuroscience Antibodies and Assays Product
Table 74. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 75. Bio-Rad Recent Developments
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Neuroscience Antibodies and Assays Product
Table 79. Merck Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 80. Merck Recent Developments
Table 81. Cell Signaling Technology Company Details
Table 82. Cell Signaling Technology Business Overview
Table 83. Cell Signaling Technology Neuroscience Antibodies and Assays Product
Table 84. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 85. Cell Signaling Technology Recent Developments
Table 86. Genscript Company Details
Table 87. Genscript Business Overview
Table 88. Genscript Neuroscience Antibodies and Assays Product
Table 89. Genscript Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 90. Genscript Recent Developments
Table 91. Rockland Immunochemicals Company Details
Table 92. Rockland Immunochemicals Business Overview
Table 93. Rockland Immunochemicals Neuroscience Antibodies and Assays Product
Table 94. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 95. Rockland Immunochemicals Recent Developments
Table 96. BioLegend Company Details
Table 97. BioLegend Business Overview
Table 98. BioLegend Neuroscience Antibodies and Assays Product
Table 99. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 100. BioLegend Recent Developments
Table 101. Santa Cruz Biotechnology Company Details
Table 102. Santa Cruz Biotechnology Business Overview
Table 103. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product
Table 104. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 105. Santa Cruz Biotechnology Recent Developments
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Neuroscience Antibodies and Assays Product
Table 109. Roche Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 110. Roche Recent Developments
Table 111. Siemens Company Details
Table 112. Siemens Business Overview
Table 113. Siemens Neuroscience Antibodies and Assays Product
Table 114. Siemens Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
Table 115. Siemens Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroscience Antibodies and Assays Market Share by Type: 2021 VS 2028
Figure 2. Consumables Features
Figure 3. Instruments Features
Figure 4. Global Neuroscience Antibodies and Assays Market Share by Application: 2021 VS 2028
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Academic & Research Institutes Case Studies
Figure 7. Hospitals & Diagnostic Centers Case Studies
Figure 8. Neuroscience Antibodies and Assays Report Years Considered
Figure 9. Global Neuroscience Antibodies and Assays Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Neuroscience Antibodies and Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Neuroscience Antibodies and Assays Market Share by Region: 2021 VS 2028
Figure 12. Global Neuroscience Antibodies and Assays Market Share by Players in 2021
Figure 13. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2021
Figure 15. North America Neuroscience Antibodies and Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Neuroscience Antibodies and Assays Market Size Market Share by Type (2017-2028)
Figure 17. North America Neuroscience Antibodies and Assays Market Size Market Share by Application (2017-2028)
Figure 18. North America Neuroscience Antibodies and Assays Market Size Share by Country (2017-2028)
Figure 19. United States Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Neuroscience Antibodies and Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Neuroscience Antibodies and Assays Market Size Market Share by Type (2017-2028)
Figure 23. Europe Neuroscience Antibodies and Assays Market Size Market Share by Application (2017-2028)
Figure 24. Europe Neuroscience Antibodies and Assays Market Size Share by Country (2017-2028)
Figure 25. Germany Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Neuroscience Antibodies and Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Neuroscience Antibodies and Assays Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Neuroscience Antibodies and Assays Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Neuroscience Antibodies and Assays Market Size Share by Region (2017-2028)
Figure 35. China Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Neuroscience Antibodies and Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Neuroscience Antibodies and Assays Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Neuroscience Antibodies and Assays Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Neuroscience Antibodies and Assays Market Size Share by Country (2017-2028)
Figure 45. Mexico Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Neuroscience Antibodies and Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Neuroscience Antibodies and Assays Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Neuroscience Antibodies and Assays Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Neuroscience Antibodies and Assays Market Size Share by Country (2017-2028)
Figure 51. Turkey Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Thermo Fisher Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 55. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 56. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 58. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 59. Genscript Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 60. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 61. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 62. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 63. Roche Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 64. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Industry Market Size
